46
Publications
2.8K
Citations
28
H-Index
1954
Active since
Affiliations
Robert L. Hamill is an author at Eli Lilly (United States) specializing in biochemistry, medicine, and pharmacology.
Top concepts
MedicineBiochemistryPharmacologyMicrobiologyNatural SciencesBiosynthesisAntibioticsAntimicrobial ResistanceEngineeringDrug Discovery
Publications per year
1954–1988
46
46
The structure op beauvericin, a new depsipeptide antibiotic toxic to
Robert L. Hamill, C. E. Higgens, Harold E. Boaz et al. · Tetrahedron Letters · 1969 · 363 citations
Rows per page
1–5 of 46